PMID: 11913762Mar 27, 2002Paper

The non-steroidal anti-inflammatory drug niflumic acid inhibits Candida albicans growth

Mycopathologia
Andrew BakerJulia M Davies

Abstract

The non-steroidal anti-inflammatory drug niflumic acid was found to inhibit growth of the yeast form of Candida albicans. Niflumic acid inhibited respiratory oxygen uptake and it is hypothesised that this was achieved by cytosolic acidification and block of glycolysis. Inhibitory concentrations are compatible with current practice of topical application.

Related Concepts

Related Feeds

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.

Related Papers

Revue française de gynécologie et d'obstétrique
P Delacroix
Revue d'odonto-stomatologie du midi de la France
R Barthelemy, M Fabie
Lille médical : journal de la Faculté de médecine et de pharmacie de l'Université de Lille
H Warembourg, G Ducloux
Revista portuguesa de estomatologia e cirurgia maxilo-facial
R Barthelemy, M Fabie
© 2022 Meta ULC. All rights reserved